Healthcare provider profile · identity verified

Brian Matthew Bedolla, MD

Allopathic & Osteopathic Physicians|General Practice · WOODBURN, OR · NPI 1649205808

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Brian Matthew Bedolla, MD received $32.24 in general payments during 2025 across 1 reported records.

Gilead Sciences, Inc. accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$32.24

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Gilead Sciences, Inc.	Unresolved — no canonical attribution shown	$32.24	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$32.24	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	878	260
Amlodipine Besylate	Amlodipine Besylate	539	160
Lisinopril	Lisinopril	482	153
Levothyroxine Sodium	Levothyroxine Sodium	459	134
Gabapentin	Gabapentin	388	139
Losartan Potassium	Losartan Potassium	365	121
Metformin Hcl	Metformin Hcl	299	89
Potassium Chloride	Potassium Chloride	295	74
Omeprazole	Omeprazole	284	98
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	258	63
Metoprolol Succinate	Metoprolol Succinate	256	78
Trazodone Hcl	Trazodone Hcl	256	89
Metformin Hcl Er	Metformin Hcl	254	86
Eliquis	Apixaban	253	70
Rosuvastatin Calcium	Rosuvastatin Calcium	244	81
Sertraline Hcl	Sertraline Hcl	236	67
Tamsulosin Hcl	Tamsulosin Hcl	235	81
Hydrochlorothiazide	Hydrochlorothiazide	179	55
Albuterol Sulfate Hfa	Albuterol Sulfate	177	77
Furosemide	Furosemide	176	59
Oxycodone Hcl	Oxycodone Hcl	174	34
Simvastatin	Simvastatin	171	50
Carvedilol	Carvedilol	170	59
Warfarin Sodium	Warfarin Sodium	164	38
Tramadol Hcl	Tramadol Hcl	145	49
Pantoprazole Sodium	Pantoprazole Sodium	137	54
Alendronate Sodium	Alendronate Sodium	136	42
Allopurinol	Allopurinol	129	37
Metoprolol Tartrate	Metoprolol Tartrate	122	38
Duloxetine Hcl	Duloxetine Hcl	118	38
Lovastatin	Lovastatin	117	38
Ozempic	Semaglutide	117	36
Jardiance	Empagliflozin	116	32
Glipizide Er	Glipizide	106	41
Famotidine	Famotidine	103	34
Mirtazapine	Mirtazapine	102	31
Meloxicam	Meloxicam	95	37
Pravastatin Sodium	Pravastatin Sodium	87	30
Bupropion Xl	Bupropion Hcl	84	29
Donepezil Hcl	Donepezil Hcl	84	30
Lorazepam	Lorazepam	83	30
Tizanidine Hcl	Tizanidine Hcl	83	19
Fluoxetine Hcl	Fluoxetine Hcl	82	30
Buspirone Hcl	Buspirone Hcl	79	22
Clopidogrel	Clopidogrel Bisulfate	78	31
Fluticasone Propionate	Fluticasone Propionate	77	32
Atenolol	Atenolol	75	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	suppressed
Montelukast Sodium	Montelukast Sodium	61	16
Finasteride	Finasteride	59	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	17
Pioglitazone Hcl	Pioglitazone Hcl	58	21
Triamcinolone Acetonide	Triamcinolone Acetonide	57	33
Pregabalin	Pregabalin	54	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	15
Valsartan	Valsartan	51	12
Memantine Hcl	Memantine Hcl	50	suppressed
Ezetimibe	Ezetimibe	48	16
Torsemide	Torsemide	48	20
Alprazolam	Alprazolam	47	suppressed
Baclofen	Baclofen	47	suppressed
Spironolactone	Spironolactone	47	17
Citalopram Hbr	Citalopram Hydrobromide	45	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	23
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	15
Doxycycline Hyclate	Doxycycline Hyclate	42	30
Escitalopram Oxalate	Escitalopram Oxalate	42	14
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	13
Cephalexin	Cephalexin	40	31
Glimepiride	Glimepiride	40	13
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	11
Ondansetron Odt	Ondansetron	39	21
Propranolol Hcl	Propranolol Hcl	38	12
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	15
Methocarbamol	Methocarbamol	36	suppressed
Glipizide	Glipizide	35	13
Amitriptyline Hcl	Amitriptyline Hcl	34	11
Ipratropium Bromide	Ipratropium Bromide	34	19
Prednisone	Prednisone	34	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	13
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Acyclovir	Acyclovir	27	13
Farxiga	Dapagliflozin Propanediol	26	suppressed
Tradjenta	Linagliptin	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Colchicine	Colchicine	23	suppressed
Estradiol	Estradiol	23	suppressed
Tresiba Flextouch U-200	Insulin Degludec	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	12
Risedronate Sodium	Risedronate Sodium	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	14
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	18
Divalproex Sodium Er	Divalproex Sodium	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Methadone Hcl	Methadone Hcl	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Digoxin	Digoxin	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Testosterone	Testosterone	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Indomethacin	Indomethacin	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Methimazole	Methimazole	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	14	14
Valacyclovir	Valacyclovir Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	12	12
Olanzapine	Olanzapine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Travoprost	Travoprost	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pen Needle	Pen Needle, Diabetic	11	suppressed
Procto-Med Hc	Hydrocortisone	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$32.24 · 1 records	Gilead Sciences, Inc.	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error